MYD88 and Sepsis: Targeting the Myd88 pathway using a peptide loaded into EVs (EVMyd88), had been described to be efficient in a model of sepsis [15], although in that study non-targeting but anti-inflammatory Mesenchymal Stem Cell vesicles were used [15], which enhanced peptide functionality in vitro.